Skip to main content
. 2019 Oct 10;6(1):e193531. doi: 10.1001/jamaoncol.2019.3531

Figure 2. Subgroup Analysis of Overall Survival Among Patients Who Had or Had Not Undergone Gastrectomy.

Figure 2.

Prespecified multivariate subgroup analysis of overall survival in the TAGS (TAS-102 Gastric Study) trial based on previous gastrectomy. This figure is adapted with permission of Elsevier Science and Technology Journals, from Shitara K et al. Trifluridine/tipiracil vs placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomized, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol 2018;19:1437-1448; permission conveyed through Copyright Clearance Center, Inc.